Glaxo, Novo, Merck lead on access to medicines according to new ranking

Get RSS feed of these results

All components of this story

18 June 2008

2008 Index outcomes

Author: Access to Medicine Foundation

This web tool enables visitors to click and sort through the outcomes of the 2008 Access to Medicine Index. The tool presents ratings and rankings of the efforts of twenty of the world’s largest pharmaceutical companies to increase universal access to medicine. Companies can be ranked according to their overall performance or according to scores on one of eight ‘main criteria’...[includes link to full 2008 Access to Medicine Index report]

🚫Read the full post here

16 June 2008

European firms beat U.S. on drug access for poor

Author: Ben Hirschler, Reuters

European drugmakers are better than their U.S. counterparts in ensuring medicines reach people in poor countries, with Britain's GlaxoSmithKline Plc leading the field, according to an analysis on Monday. The ranking -- the first of its kind -- was produced by the Netherlands-based Access to Medicine Foundation and is backed by 12 fund managers, who together manage $1.2 trillion in assets. The ranking is based on eight main criteria, including companies' policies on increasing access, patenting, research into neglected diseases and the use of fair pricing systems...
The full ranking is as follows:
GlaxoSmithKline PLC
Novo Nordisk [part of Novo Group]
Merck & Company Inc
Novartis AG
AstraZenica PLC
Roche Holdings Limited
Johnson & Johnson
Bayer Schering Pharma AG [part of Bayer]
Eli Lilly & Company
Bristol-Myers Squibb Comp
Abbott Laboratories Ltd
Merck Kgaa AG
Cipla Limited
Gilead Sciences Inc
Ranbaxy Laboratories Ltd
Pfizer Inc
Teva Pharmaceutical...
Schering-Plough Corp

🚫Read the full post here